Genentech, Inc.
About Genentech, Inc.
1691 articles about Genentech, Inc.
-
Genentech, Inc. Announces Resubmission of Supplemental Biologics License Application for Avastin in Combination with Paclitaxel for First-Line Metastatic Breast Cancer
8/24/2007
-
The New Job Scene in Biotech Bay
8/20/2007
-
Mount Sinai Medical Center Release: Drug Effective In Treatment of Heavy Psoriasis Patients
8/3/2007
-
Genentech, Inc. Announces Expiration of Hart-Scott-Rodino Waiting Period and Completes Acquisition of Tanox, Inc.
8/2/2007
-
ImmunoGen, Inc. Earns Milestone from Genentech, Inc. with Start of Trastuzumab-DM1 Phase II Testing
7/31/2007
-
San Diego Biotech Plant Gets Go-Ahead, Genentech, Inc. (Jobs) to Offer Hundreds of Jobs
7/23/2007
-
Genentech, Inc. Announces Second Quarter 2007 Results
7/12/2007
-
Celgene (Jobs), Genentech, Inc. (Jobs), Gilead Sciences, Inc. (Jobs): Is Biotech Weakness Creating A Buying Opportunity?
7/5/2007
-
Out at Work: Diversity in the Pharmaceutical and Biotechnology Industries
6/29/2007
-
Abbott Laboratories (Jobs) and Genentech, Inc. (Jobs) to Co-Develop Two Cancer Drugs
6/26/2007
-
Genentech, Inc. Announces July 11 Webcast Discussion of Earnings and Other Business Results
6/21/2007
-
Biotech Pioneer Defends Its Turf : Genentech, Inc.(Jobs) is Busy on New Therapies to Combat Cancer
6/11/2007
-
Genentech, Inc.: Updated Overall Survival Data From Pivotal Herceptin Adjuvant Studies in HER2-Positive Breast Cancer
6/4/2007
-
Genentech, Inc.'s Phase III Study Shows Avastin Plus Interferon Therapy Nearly Doubled Median Progression-Free Survival in Patients With Previously Untreated Advanced Kidney Cancer
6/4/2007
-
Genentech, Inc. Provides Update on Pipeline Agents at the American Society of Clinical Oncology Meeting
6/4/2007
-
Genentech, Inc. (Jobs) Shares Slip on Second Phase III Study of Avastin Results; Smaller Dose More Effective
6/4/2007
-
Ventana Medical Systems, Inc. and Genentech, Inc. (Jobs) in Development Pact
5/24/2007
-
Genentech, Inc. Announces June 4 Webcast Discussion of Data Presented at American Society of Clinical Oncology
5/14/2007
-
Genentech, Inc. Release: Rituxan(R) Phase II Data in Patients with Relapsing-Remitting Multiple Sclerosis Presented at the American Academy of Neurology; Drug Shows Promise
5/1/2007
-
Sangamo BioSciences, Inc. (Jobs) Says Genentech, Inc. (Jobs) Licenses Gene-Modifying Technology
4/30/2007